

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to parathyroid hormone (GO:0071107) | 8.37138889 |
| 2 | cellular potassium ion homeostasis (GO:0030007) | 7.63455328 |
| 3 | sodium ion export (GO:0071436) | 7.44976124 |
| 4 | membrane repolarization during action potential (GO:0086011) | 7.43484581 |
| 5 | endocrine pancreas development (GO:0031018) | 7.33221620 |
| 6 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 7.04107514 |
| 7 | protein maturation by protein folding (GO:0022417) | 6.95218417 |
| 8 | peptide hormone processing (GO:0016486) | 6.87236865 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.69257087 |
| 10 | COPII vesicle coating (GO:0048208) | 6.60637241 |
| 11 | response to lipoprotein particle (GO:0055094) | 6.56750754 |
| 12 | protein retention in ER lumen (GO:0006621) | 6.16985094 |
| 13 | nodal signaling pathway (GO:0038092) | 6.11667491 |
| 14 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 6.09059389 |
| 15 | trivalent inorganic anion homeostasis (GO:0072506) | 6.02545945 |
| 16 | phosphate ion homeostasis (GO:0055062) | 6.02545945 |
| 17 | glandular epithelial cell differentiation (GO:0002067) | 5.90579704 |
| 18 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 5.83458928 |
| 19 | norepinephrine metabolic process (GO:0042415) | 5.66499584 |
| 20 | positive regulation of glycogen biosynthetic process (GO:0045725) | 5.57080166 |
| 21 | type B pancreatic cell development (GO:0003323) | 5.52065702 |
| 22 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.44898514 |
| 23 | insulin secretion (GO:0030073) | 5.34934410 |
| 24 | signal peptide processing (GO:0006465) | 5.34389400 |
| 25 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.29677589 |
| 26 | positive regulation of insulin secretion (GO:0032024) | 5.28347009 |
| 27 | membrane repolarization (GO:0086009) | 5.27807793 |
| 28 | cellular anion homeostasis (GO:0030002) | 5.27205768 |
| 29 | sequestering of metal ion (GO:0051238) | 5.21462601 |
| 30 | glandular epithelial cell development (GO:0002068) | 5.20985578 |
| 31 | positive regulation of nuclease activity (GO:0032075) | 5.19103370 |
| 32 | exocrine pancreas development (GO:0031017) | 5.14371899 |
| 33 | potassium ion homeostasis (GO:0055075) | 5.11238131 |
| 34 | vesicle coating (GO:0006901) | 5.10596130 |
| 35 | potassium ion import (GO:0010107) | 4.89440935 |
| 36 | positive regulation of glycogen metabolic process (GO:0070875) | 4.82207855 |
| 37 | relaxation of cardiac muscle (GO:0055119) | 4.77096142 |
| 38 | regulation of nuclease activity (GO:0032069) | 4.73374090 |
| 39 | regulation of insulin secretion (GO:0050796) | 4.72885591 |
| 40 | cell communication by electrical coupling (GO:0010644) | 4.66967819 |
| 41 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.57073389 |
| 42 | cellular sodium ion homeostasis (GO:0006883) | 4.56970074 |
| 43 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.52504081 |
| 44 | cellular response to unfolded protein (GO:0034620) | 4.43866876 |
| 45 | ER overload response (GO:0006983) | 4.43334659 |
| 46 | ganglion development (GO:0061548) | 4.43142319 |
| 47 | cellular response to vitamin (GO:0071295) | 4.41813851 |
| 48 | cellular response to topologically incorrect protein (GO:0035967) | 4.32722216 |
| 49 | regulation of peptide hormone secretion (GO:0090276) | 4.31127551 |
| 50 | nitric oxide mediated signal transduction (GO:0007263) | 4.30575889 |
| 51 | positive regulation of peptide hormone secretion (GO:0090277) | 4.28621731 |
| 52 | toxin metabolic process (GO:0009404) | 4.27087053 |
| 53 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.27023774 |
| 54 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.25340295 |
| 55 | regulation of peptide secretion (GO:0002791) | 4.23588620 |
| 56 | ER-nucleus signaling pathway (GO:0006984) | 4.23227103 |
| 57 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.20859826 |
| 58 | positive regulation of peptide secretion (GO:0002793) | 4.15162300 |
| 59 | detection of calcium ion (GO:0005513) | 4.12720704 |
| 60 | columnar/cuboidal epithelial cell development (GO:0002066) | 4.11520839 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.09115851 |
| 62 | synaptic vesicle maturation (GO:0016188) | 4.07182607 |
| 63 | response to lead ion (GO:0010288) | 4.06261641 |
| 64 | intra-Golgi vesicle-mediated transport (GO:0006891) | 4.05884828 |
| 65 | peptide hormone secretion (GO:0030072) | 4.01590028 |
| 66 | glutamate secretion (GO:0014047) | 3.95767804 |
| 67 | cellular response to vitamin D (GO:0071305) | 3.94274140 |
| 68 | peptide secretion (GO:0002790) | 3.92588784 |
| 69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.92276631 |
| 70 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.92118776 |
| 71 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.87058617 |
| 72 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.78520882 |
| 73 | negative regulation of insulin secretion (GO:0046676) | 3.75386250 |
| 74 | negative regulation of norepinephrine secretion (GO:0010700) | 3.74717622 |
| 75 | regulation of hormone secretion (GO:0046883) | 3.73185888 |
| 76 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.73126353 |
| 77 | response to vitamin D (GO:0033280) | 3.72764293 |
| 78 | negative regulation of catecholamine secretion (GO:0033604) | 3.70250991 |
| 79 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.69597664 |
| 80 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.69388248 |
| 81 | peptidyl-asparagine modification (GO:0018196) | 3.67657827 |
| 82 | response to endoplasmic reticulum stress (GO:0034976) | 3.65811153 |
| 83 | epithelial cell fate commitment (GO:0072148) | 3.64671536 |
| 84 | cell communication involved in cardiac conduction (GO:0086065) | 3.60357712 |
| 85 | negative regulation of microtubule polymerization (GO:0031115) | 3.59474734 |
| 86 | macroautophagy (GO:0016236) | 3.59219475 |
| 87 | catecholamine biosynthetic process (GO:0042423) | 3.58125467 |
| 88 | catechol-containing compound biosynthetic process (GO:0009713) | 3.58125467 |
| 89 | astrocyte differentiation (GO:0048708) | 3.51885611 |
| 90 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.49555574 |
| 91 | regulation of peptide transport (GO:0090087) | 3.47965637 |
| 92 | cellular zinc ion homeostasis (GO:0006882) | 3.47545390 |
| 93 | behavioral response to nicotine (GO:0035095) | 3.45581833 |
| 94 | protein localization to Golgi apparatus (GO:0034067) | 3.44422313 |
| 95 | negative regulation of gluconeogenesis (GO:0045721) | 3.44418014 |
| 96 | positive regulation of Rap GTPase activity (GO:0032854) | 3.44007610 |
| 97 | response to unfolded protein (GO:0006986) | 3.41606394 |
| 98 | skin morphogenesis (GO:0043589) | 3.41174773 |
| 99 | myelin maintenance (GO:0043217) | 3.39180932 |
| 100 | cellular response to glucagon stimulus (GO:0071377) | 3.38133209 |
| 101 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.37063922 |
| 102 | protein N-linked glycosylation (GO:0006487) | 3.36996274 |
| 103 | positive regulation of hormone secretion (GO:0046887) | 3.36421251 |
| 104 | response to topologically incorrect protein (GO:0035966) | 3.33066858 |
| 105 | response to dietary excess (GO:0002021) | 3.30710062 |
| 106 | cerebellar Purkinje cell layer development (GO:0021680) | 3.29601341 |
| 107 | negative regulation of peptide hormone secretion (GO:0090278) | 3.27603212 |
| 108 | response to hexose (GO:0009746) | 3.26359514 |
| 109 | Golgi organization (GO:0007030) | 3.25809825 |
| 110 | regulation of glucocorticoid secretion (GO:2000849) | 3.22314619 |
| 111 | response to glucose (GO:0009749) | 3.22128438 |
| 112 | ear development (GO:0043583) | 3.20188976 |
| 113 | bone morphogenesis (GO:0060349) | 3.18897681 |
| 114 | positive regulation of calcium ion import (GO:0090280) | 3.18011720 |
| 115 | hormone secretion (GO:0046879) | 3.17322102 |
| 116 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.17270417 |
| 117 | regulation of glycogen biosynthetic process (GO:0005979) | 3.16345169 |
| 118 | regulation of glucan biosynthetic process (GO:0010962) | 3.16345169 |
| 119 | negative regulation of peptide secretion (GO:0002792) | 3.15636292 |
| 120 | peptide transport (GO:0015833) | 3.15121308 |
| 121 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.15056999 |
| 122 | response to ischemia (GO:0002931) | 3.14348470 |
| 123 | response to hepatocyte growth factor (GO:0035728) | 3.14253718 |
| 124 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.14253718 |
| 125 | negative regulation of bone resorption (GO:0045779) | 3.11387227 |
| 126 | response to monosaccharide (GO:0034284) | 3.10280864 |
| 127 | positive regulation of glucose import (GO:0046326) | 3.09687991 |
| 128 | positive regulation of glucose metabolic process (GO:0010907) | 3.08280175 |
| 129 | hormone transport (GO:0009914) | 3.05093830 |
| 130 | receptor recycling (GO:0001881) | 3.04889981 |
| 131 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.04831315 |
| 132 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.04424824 |
| 133 | protein autoprocessing (GO:0016540) | 3.04416493 |
| 134 | proline transport (GO:0015824) | 3.04394588 |
| 135 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.02553450 |
| 136 | Golgi vesicle transport (GO:0048193) | 3.01214635 |
| 137 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 3.00519270 |
| 138 | glucose 6-phosphate metabolic process (GO:0051156) | 2.99111140 |
| 139 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.99009082 |
| 140 | carbohydrate homeostasis (GO:0033500) | 2.98254244 |
| 141 | glucose homeostasis (GO:0042593) | 2.98254244 |
| 142 | protein targeting to Golgi (GO:0000042) | 2.97715510 |
| 143 | growth hormone secretion (GO:0030252) | 2.97200683 |
| 144 | inner ear receptor cell development (GO:0060119) | 2.95858929 |
| 145 | regulation of Rap GTPase activity (GO:0032317) | 2.93652111 |
| 146 | positive regulation of glycolytic process (GO:0045821) | 2.93571778 |
| 147 | thymus development (GO:0048538) | 2.93506643 |
| 148 | body morphogenesis (GO:0010171) | 2.93419465 |
| 149 | chemosensory behavior (GO:0007635) | 2.91280171 |
| 150 | relaxation of muscle (GO:0090075) | 2.89500947 |
| 151 | GDP-mannose metabolic process (GO:0019673) | 2.86924886 |
| 152 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.86527188 |
| 153 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.86259249 |
| 154 | calcium ion import (GO:0070509) | 2.84872450 |
| 155 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.84330143 |
| 156 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.84045718 |
| 157 | intestinal epithelial cell development (GO:0060576) | 2.83678316 |
| 158 | positive regulation of potassium ion transport (GO:0043268) | 2.81341982 |
| 159 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.80812864 |
| 160 | regulation of norepinephrine secretion (GO:0014061) | 2.80720914 |
| 161 | regulation of glucokinase activity (GO:0033131) | 2.79939692 |
| 162 | regulation of hexokinase activity (GO:1903299) | 2.79939692 |
| 163 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.78685427 |
| 164 | activin receptor signaling pathway (GO:0032924) | 2.77669350 |
| 165 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.73572144 |
| 166 | cellular response to leptin stimulus (GO:0044320) | 2.72947439 |
| 167 | positive regulation of glucose transport (GO:0010828) | 2.71638533 |
| 168 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.68207199 |
| 169 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.66059957 |
| 170 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.65600311 |
| 171 | regulation of glycogen metabolic process (GO:0070873) | 2.65467316 |
| 172 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.64351351 |
| 173 | neurotransmitter secretion (GO:0007269) | 2.60656331 |
| 174 | positive regulation of transcription regulatory region DNA binding (GO:2000679) | 2.59542675 |
| 175 | positive regulation of sodium ion transport (GO:0010765) | 2.59495307 |
| 176 | Golgi transport vesicle coating (GO:0048200) | 11.1227731 |
| 177 | COPI coating of Golgi vesicle (GO:0048205) | 11.1227731 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 4.07322360 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 3.99970034 |
| 3 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.64860389 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.77230825 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.72404095 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.70726716 |
| 7 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.67925006 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.65767775 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.54404065 |
| 10 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.44972887 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.43349332 |
| 12 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.40171844 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34893656 |
| 14 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.32064161 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26582656 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26582656 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.21235030 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.18428256 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.09536299 |
| 20 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 10.3161341 |
| 21 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.96498166 |
| 22 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.94577011 |
| 23 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.94342266 |
| 24 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.92397504 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.88265404 |
| 26 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.84248127 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.81738161 |
| 28 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.80453731 |
| 29 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.78988972 |
| 30 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.75325802 |
| 31 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.75228524 |
| 32 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.69562916 |
| 33 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.68110874 |
| 34 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.63887992 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61041655 |
| 36 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.59318630 |
| 37 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.58596027 |
| 38 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.54445014 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54363002 |
| 40 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.52837262 |
| 41 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52186970 |
| 42 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.48180679 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47667283 |
| 44 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.45523035 |
| 45 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.43182363 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41288975 |
| 47 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.39443381 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39432435 |
| 49 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37624673 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.34822720 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.33210493 |
| 52 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.33019974 |
| 53 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32494002 |
| 54 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.31635534 |
| 55 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.26406580 |
| 56 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25792006 |
| 57 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24221736 |
| 58 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.23399987 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22928972 |
| 60 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.22316965 |
| 61 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21103317 |
| 62 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.20641152 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.20351023 |
| 64 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.19880268 |
| 65 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19089183 |
| 66 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.18830157 |
| 67 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.17819127 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17769142 |
| 69 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17568558 |
| 70 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17123192 |
| 71 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.17115210 |
| 72 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.16944365 |
| 73 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.15579968 |
| 74 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.15424242 |
| 75 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15272311 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.14576910 |
| 77 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.13688046 |
| 78 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.12868496 |
| 79 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12729427 |
| 80 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.10101818 |
| 81 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10097442 |
| 82 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09576326 |
| 83 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09174308 |
| 84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.08139414 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07234990 |
| 86 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.06714871 |
| 87 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06583741 |
| 88 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05927057 |
| 89 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.05603618 |
| 90 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04706412 |
| 91 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.01934030 |
| 92 | GF1_26923725_Chip-Seq_HPCs_Mouse | 1.01533870 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00906761 |
| 94 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00297242 |
| 95 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99233531 |
| 96 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98746472 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98432781 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.97311786 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.96472458 |
| 100 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95866885 |
| 101 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.95671593 |
| 102 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95067828 |
| 103 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94843265 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94707346 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94293060 |
| 106 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.92619572 |
| 107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.92509157 |
| 108 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.92356106 |
| 109 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92267463 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92099590 |
| 111 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91127921 |
| 112 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91123601 |
| 113 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90971913 |
| 114 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.90665522 |
| 115 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90639088 |
| 116 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.90301971 |
| 117 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.90029318 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.88886964 |
| 119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88540688 |
| 120 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87673887 |
| 121 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86059695 |
| 122 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85575496 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.85076067 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.84892600 |
| 125 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84367668 |
| 126 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84284088 |
| 127 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83739575 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.83534320 |
| 129 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.82372702 |
| 130 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81814194 |
| 131 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.81716691 |
| 132 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81651977 |
| 133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.80789091 |
| 134 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.80728169 |
| 135 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.80377791 |
| 136 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.79385396 |
| 137 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.78948610 |
| 138 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.78695522 |
| 139 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.77446955 |
| 140 | AR_19668381_ChIP-Seq_PC3_Human | 0.77324602 |
| 141 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.76681395 |
| 142 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.76493826 |
| 143 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.76380784 |
| 144 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.75693054 |
| 145 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75314038 |
| 146 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.74550386 |
| 147 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.74046691 |
| 148 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.74027399 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73807612 |
| 150 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.73766650 |
| 151 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.73766650 |
| 152 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.73353733 |
| 153 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73332071 |
| 154 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.73171142 |
| 155 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.73161153 |
| 156 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.72882099 |
| 157 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.72669918 |
| 158 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72635042 |
| 159 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.72510718 |
| 160 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.72108270 |
| 161 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.71513794 |
| 162 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71416157 |
| 163 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.71400644 |
| 164 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.70944649 |
| 165 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.70903115 |
| 166 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.70330747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 6.44460562 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 5.44056530 |
| 3 | MP0003283_abnormal_digestive_organ | 5.25381738 |
| 4 | MP0002693_abnormal_pancreas_physiology | 4.36300545 |
| 5 | MP0000013_abnormal_adipose_tissue | 4.30465292 |
| 6 | MP0005367_renal/urinary_system_phenotyp | 4.30456569 |
| 7 | MP0000516_abnormal_urinary_system | 4.30456569 |
| 8 | MP0002822_catalepsy | 4.29042075 |
| 9 | MP0004043_abnormal_pH_regulation | 4.25973668 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 4.02206759 |
| 11 | MP0001944_abnormal_pancreas_morphology | 3.93121253 |
| 12 | MP0003195_calcinosis | 3.83880609 |
| 13 | MP0005379_endocrine/exocrine_gland_phen | 3.58674485 |
| 14 | MP0003183_abnormal_peptide_metabolism | 3.54468498 |
| 15 | MP0000678_abnormal_parathyroid_gland | 3.40795762 |
| 16 | MP0010386_abnormal_urinary_bladder | 3.34499001 |
| 17 | * MP0002909_abnormal_adrenal_gland | 2.95679410 |
| 18 | MP0005220_abnormal_exocrine_pancreas | 2.79948654 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 2.63417240 |
| 20 | MP0002078_abnormal_glucose_homeostasis | 2.43447700 |
| 21 | MP0000003_abnormal_adipose_tissue | 2.33248346 |
| 22 | MP0002938_white_spotting | 2.29034444 |
| 23 | MP0006072_abnormal_retinal_apoptosis | 2.16590882 |
| 24 | MP0005645_abnormal_hypothalamus_physiol | 2.15085826 |
| 25 | MP0003122_maternal_imprinting | 2.06064377 |
| 26 | MP0004264_abnormal_extraembryonic_tissu | 2.01269834 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.92854637 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.90660918 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.90058114 |
| 30 | MP0004859_abnormal_synaptic_plasticity | 1.80726064 |
| 31 | MP0002234_abnormal_pharynx_morphology | 1.76431757 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.70141824 |
| 33 | MP0001765_abnormal_ion_homeostasis | 1.68897237 |
| 34 | MP0002928_abnormal_bile_duct | 1.65399519 |
| 35 | MP0004270_analgesia | 1.65277030 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.63814147 |
| 37 | MP0000462_abnormal_digestive_system | 1.63776986 |
| 38 | MP0002896_abnormal_bone_mineralization | 1.56530749 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.49723372 |
| 40 | * MP0003953_abnormal_hormone_level | 1.46210097 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.39274817 |
| 42 | MP0000613_abnormal_salivary_gland | 1.37617987 |
| 43 | MP0002163_abnormal_gland_morphology | 1.30534488 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.27683426 |
| 45 | MP0003959_abnormal_lean_body | 1.22807371 |
| 46 | MP0000631_abnormal_neuroendocrine_gland | 1.22486255 |
| 47 | MP0003868_abnormal_feces_composition | 1.20607374 |
| 48 | MP0005257_abnormal_intraocular_pressure | 1.19989451 |
| 49 | MP0001756_abnormal_urination | 1.17077317 |
| 50 | MP0010234_abnormal_vibrissa_follicle | 1.13579234 |
| 51 | MP0000639_abnormal_adrenal_gland | 1.11439323 |
| 52 | MP0005535_abnormal_body_temperature | 1.11206313 |
| 53 | MP0009745_abnormal_behavioral_response | 1.10931276 |
| 54 | * MP0009643_abnormal_urine_homeostasis | 1.08739340 |
| 55 | MP0003119_abnormal_digestive_system | 1.08151921 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.07920197 |
| 57 | MP0003635_abnormal_synaptic_transmissio | 1.06085474 |
| 58 | MP0009250_abnormal_appendicular_skeleto | 1.03592383 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.01671233 |
| 60 | MP0001270_distended_abdomen | 1.01372353 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.01008775 |
| 62 | MP0003252_abnormal_bile_duct | 1.00843215 |
| 63 | MP0005409_darkened_coat_color | 1.00713955 |
| 64 | MP0005365_abnormal_bile_salt | 1.00004880 |
| 65 | MP0005375_adipose_tissue_phenotype | 0.99211646 |
| 66 | MP0006054_spinal_hemorrhage | 0.99145889 |
| 67 | MP0003633_abnormal_nervous_system | 0.98965233 |
| 68 | MP0003787_abnormal_imprinting | 0.96675380 |
| 69 | MP0000470_abnormal_stomach_morphology | 0.96292388 |
| 70 | MP0005310_abnormal_salivary_gland | 0.95843072 |
| 71 | MP0002876_abnormal_thyroid_physiology | 0.94152523 |
| 72 | MP0002063_abnormal_learning/memory/cond | 0.92711545 |
| 73 | MP0005448_abnormal_energy_balance | 0.91606401 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 0.90785304 |
| 75 | MP0000733_abnormal_muscle_development | 0.88152450 |
| 76 | MP0003329_amyloid_beta_deposits | 0.86777465 |
| 77 | MP0001958_emphysema | 0.85858785 |
| 78 | MP0003866_abnormal_defecation | 0.85492742 |
| 79 | MP0008260_abnormal_autophagy | 0.83522089 |
| 80 | MP0002733_abnormal_thermal_nociception | 0.81919861 |
| 81 | MP0004484_altered_response_of | 0.81860814 |
| 82 | MP0005508_abnormal_skeleton_morphology | 0.81833787 |
| 83 | MP0000681_abnormal_thyroid_gland | 0.81624158 |
| 84 | MP0002734_abnormal_mechanical_nocicepti | 0.81346599 |
| 85 | MP0002064_seizures | 0.80889247 |
| 86 | MP0004215_abnormal_myocardial_fiber | 0.80651340 |
| 87 | MP0005253_abnormal_eye_physiology | 0.79988663 |
| 88 | MP0001299_abnormal_eye_distance/ | 0.79688076 |
| 89 | MP0005187_abnormal_penis_morphology | 0.79447856 |
| 90 | MP0008877_abnormal_DNA_methylation | 0.75230009 |
| 91 | MP0004145_abnormal_muscle_electrophysio | 0.75203828 |
| 92 | MP0000538_abnormal_urinary_bladder | 0.74390773 |
| 93 | MP0003879_abnormal_hair_cell | 0.74064611 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 0.73527134 |
| 95 | MP0003045_fibrosis | 0.73190923 |
| 96 | MP0009672_abnormal_birth_weight | 0.71221121 |
| 97 | MP0006276_abnormal_autonomic_nervous | 0.68962902 |
| 98 | MP0002249_abnormal_larynx_morphology | 0.65892759 |
| 99 | MP0002108_abnormal_muscle_morphology | 0.64754022 |
| 100 | MP0001666_abnormal_nutrient_absorption | 0.63643831 |
| 101 | MP0003880_abnormal_central_pattern | 0.63514923 |
| 102 | * MP0000230_abnormal_systemic_arterial | 0.62441199 |
| 103 | MP0005423_abnormal_somatic_nervous | 0.62215189 |
| 104 | MP0002069_abnormal_eating/drinking_beha | 0.61475276 |
| 105 | MP0002932_abnormal_joint_morphology | 0.61179020 |
| 106 | MP0004924_abnormal_behavior | 0.60991113 |
| 107 | MP0005386_behavior/neurological_phenoty | 0.60991113 |
| 108 | MP0001905_abnormal_dopamine_level | 0.60873189 |
| 109 | MP0005166_decreased_susceptibility_to | 0.60009130 |
| 110 | MP0006292_abnormal_olfactory_placode | 0.59272476 |
| 111 | MP0005452_abnormal_adipose_tissue | 0.59253998 |
| 112 | MP0003631_nervous_system_phenotype | 0.58264397 |
| 113 | MP0000955_abnormal_spinal_cord | 0.58246900 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.58084874 |
| 115 | MP0001661_extended_life_span | 0.57113822 |
| 116 | MP0001970_abnormal_pain_threshold | 0.57018087 |
| 117 | MP0002735_abnormal_chemical_nociception | 0.56917222 |
| 118 | MP0009703_decreased_birth_body | 0.56721800 |
| 119 | MP0002272_abnormal_nervous_system | 0.56498941 |
| 120 | MP0005334_abnormal_fat_pad | 0.56185818 |
| 121 | MP0003123_paternal_imprinting | 0.56030797 |
| 122 | MP0002751_abnormal_autonomic_nervous | 0.55095805 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.54810187 |
| 124 | MP0001984_abnormal_olfaction | 0.54474283 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.54250227 |
| 126 | MP0005670_abnormal_white_adipose | 0.53081695 |
| 127 | MP0002139_abnormal_hepatobiliary_system | 0.52755904 |
| 128 | MP0001188_hyperpigmentation | 0.52253466 |
| 129 | * MP0009642_abnormal_blood_homeostasis | 0.52025254 |
| 130 | MP0003121_genomic_imprinting | 0.51761722 |
| 131 | MP0001664_abnormal_digestion | 0.51048895 |
| 132 | MP0000163_abnormal_cartilage_morphology | 0.50943695 |
| 133 | MP0003795_abnormal_bone_structure | 0.47476955 |
| 134 | MP0002177_abnormal_outer_ear | 0.47474740 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.47139915 |
| 136 | MP0001943_abnormal_respiration | 0.46991565 |
| 137 | MP0008569_lethality_at_weaning | 0.46816366 |
| 138 | MP0005408_hypopigmentation | 0.46413243 |
| 139 | MP0009840_abnormal_foam_cell | 0.46262326 |
| 140 | MP0004085_abnormal_heartbeat | 0.46261033 |
| 141 | MP0001486_abnormal_startle_reflex | 0.45857440 |
| 142 | MP0002229_neurodegeneration | 0.45294612 |
| 143 | MP0002168_other_aberrant_phenotype | 0.45202725 |
| 144 | MP0002970_abnormal_white_adipose | 0.44846379 |
| 145 | MP0001440_abnormal_grooming_behavior | 0.44524842 |
| 146 | MP0003938_abnormal_ear_development | 0.43792819 |
| 147 | MP0002557_abnormal_social/conspecific_i | 0.43295210 |
| 148 | MP0002796_impaired_skin_barrier | 0.42720071 |
| 149 | MP0005503_abnormal_tendon_morphology | 0.41964439 |
| 150 | MP0003634_abnormal_glial_cell | 0.40762803 |
| 151 | MP0000377_abnormal_hair_follicle | 0.40180403 |
| 152 | MP0004782_abnormal_surfactant_physiolog | 0.39848467 |
| 153 | MP0002116_abnormal_craniofacial_bone | 0.38910619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 8.45119863 |
| 2 | Hypoglycemic seizures (HP:0002173) | 7.68461789 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.36827441 |
| 4 | Symptomatic seizures (HP:0011145) | 6.96409575 |
| 5 | Alacrima (HP:0000522) | 6.82294756 |
| 6 | Hypoglycemic coma (HP:0001325) | 6.63380977 |
| 7 | Decreased lacrimation (HP:0000633) | 5.51739112 |
| 8 | Microretrognathia (HP:0000308) | 5.44444596 |
| 9 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.36333615 |
| 10 | Hyperglycemia (HP:0003074) | 5.28429012 |
| 11 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.12595685 |
| 12 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.12595685 |
| 13 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.95619245 |
| 14 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.83806373 |
| 15 | Ketoacidosis (HP:0001993) | 4.76499619 |
| 16 | Nasolacrimal duct obstruction (HP:0000579) | 4.67646215 |
| 17 | Large for gestational age (HP:0001520) | 4.65243657 |
| 18 | Hypocalcemia (HP:0002901) | 4.61101406 |
| 19 | Mixed hearing impairment (HP:0000410) | 4.59621362 |
| 20 | Late onset (HP:0003584) | 4.47442179 |
| 21 | Hypoparathyroidism (HP:0000829) | 4.38611343 |
| 22 | Decreased circulating renin level (HP:0003351) | 4.28542632 |
| 23 | Abnormal pancreas size (HP:0012094) | 3.98369714 |
| 24 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.71278829 |
| 25 | Mucopolysacchariduria (HP:0008155) | 3.71278829 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.60530336 |
| 27 | Abnormality of the lacrimal duct (HP:0011481) | 3.59389671 |
| 28 | Preauricular pit (HP:0004467) | 3.58422825 |
| 29 | Periauricular skin pits (HP:0100277) | 3.58422825 |
| 30 | Metaphyseal irregularity (HP:0003025) | 3.56992324 |
| 31 | Agitation (HP:0000713) | 3.48298006 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.42622151 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.42622151 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.42622151 |
| 35 | Hypokalemia (HP:0002900) | 3.40153854 |
| 36 | Hyperparathyroidism (HP:0000843) | 3.25728737 |
| 37 | Insulin resistance (HP:0000855) | 3.23598430 |
| 38 | Abnormality of the nasolacrimal system (HP:0000614) | 3.18858315 |
| 39 | Generalized aminoaciduria (HP:0002909) | 3.18303194 |
| 40 | J-shaped sella turcica (HP:0002680) | 3.13871287 |
| 41 | Prominent metopic ridge (HP:0005487) | 3.01319794 |
| 42 | Abnormality of renin-angiotensin system (HP:0000847) | 2.97632042 |
| 43 | Intellectual disability, moderate (HP:0002342) | 2.97291537 |
| 44 | Scapular winging (HP:0003691) | 2.93366988 |
| 45 | Osteomalacia (HP:0002749) | 2.92502438 |
| 46 | Retinal atrophy (HP:0001105) | 2.89940316 |
| 47 | Hypomagnesemia (HP:0002917) | 2.75578582 |
| 48 | Abnormality of potassium homeostasis (HP:0011042) | 2.75553437 |
| 49 | Abnormality of the antihelix (HP:0009738) | 2.74587568 |
| 50 | Abnormality of magnesium homeostasis (HP:0004921) | 2.74336324 |
| 51 | Enlarged penis (HP:0000040) | 2.73676105 |
| 52 | Hyperthyroidism (HP:0000836) | 2.71160084 |
| 53 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70839372 |
| 54 | Unilateral renal agenesis (HP:0000122) | 2.69445943 |
| 55 | Thin bony cortex (HP:0002753) | 2.66211789 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.64664657 |
| 57 | Skin pits (HP:0100276) | 2.63830014 |
| 58 | Menstrual irregularities (HP:0000858) | 2.63191730 |
| 59 | Hyperkalemia (HP:0002153) | 2.63007933 |
| 60 | Ketosis (HP:0001946) | 2.62372241 |
| 61 | Dysautonomia (HP:0002459) | 2.61330405 |
| 62 | EEG with generalized epileptiform discharges (HP:0011198) | 2.56846323 |
| 63 | Abnormality of the metopic suture (HP:0005556) | 2.56797530 |
| 64 | Hypsarrhythmia (HP:0002521) | 2.54772128 |
| 65 | Hypercortisolism (HP:0001578) | 2.54567903 |
| 66 | Basal ganglia calcification (HP:0002135) | 2.50925026 |
| 67 | Pheochromocytoma (HP:0002666) | 2.47937021 |
| 68 | Papilledema (HP:0001085) | 2.47932200 |
| 69 | Hypercalciuria (HP:0002150) | 2.46849525 |
| 70 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.45327598 |
| 71 | Epileptiform EEG discharges (HP:0011182) | 2.45262409 |
| 72 | Hyperactive renin-angiotensin system (HP:0000841) | 2.44095087 |
| 73 | Thoracolumbar scoliosis (HP:0002944) | 2.37972111 |
| 74 | Limb hypertonia (HP:0002509) | 2.34394506 |
| 75 | Hypothermia (HP:0002045) | 2.32534352 |
| 76 | Ventricular fibrillation (HP:0001663) | 2.32494493 |
| 77 | Hyperphosphatemia (HP:0002905) | 2.31806709 |
| 78 | Chronic bronchitis (HP:0004469) | 2.30280885 |
| 79 | Increased circulating renin level (HP:0000848) | 2.29811153 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.27822361 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.26467180 |
| 82 | Exocrine pancreatic insufficiency (HP:0001738) | 2.24674180 |
| 83 | Hypoplasia of the fovea (HP:0007750) | 2.21999308 |
| 84 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.21999308 |
| 85 | Neonatal hypoglycemia (HP:0001998) | 2.20095172 |
| 86 | Hypotension (HP:0002615) | 2.18633205 |
| 87 | Visual hallucinations (HP:0002367) | 2.17290395 |
| 88 | Abdominal distention (HP:0003270) | 2.15652076 |
| 89 | Restlessness (HP:0000711) | 2.15026609 |
| 90 | Thickened calvaria (HP:0002684) | 2.14756185 |
| 91 | Abnormality of the fovea (HP:0000493) | 2.13639665 |
| 92 | Tapered finger (HP:0001182) | 2.12052353 |
| 93 | Neuroendocrine neoplasm (HP:0100634) | 2.11065650 |
| 94 | Adrenal overactivity (HP:0002717) | 2.09016420 |
| 95 | Oligodontia (HP:0000677) | 2.06375599 |
| 96 | Hypophosphatemia (HP:0002148) | 2.05465764 |
| 97 | Congenital glaucoma (HP:0001087) | 2.04762604 |
| 98 | Polydipsia (HP:0001959) | 2.03806585 |
| 99 | Abnormal drinking behavior (HP:0030082) | 2.03806585 |
| 100 | Abnormal urine phosphate concentration (HP:0012599) | 2.01744284 |
| 101 | Gout (HP:0001997) | 2.00729216 |
| 102 | Hypercalcemia (HP:0003072) | 2.00375513 |
| 103 | Tetany (HP:0001281) | 10.6652956 |
| 104 | Abnormal protein glycosylation (HP:0012346) | 1.96020753 |
| 105 | Abnormal glycosylation (HP:0012345) | 1.96020753 |
| 106 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.96020753 |
| 107 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.96020753 |
| 108 | Growth hormone excess (HP:0000845) | 1.94156285 |
| 109 | Abnormality of chloride homeostasis (HP:0011422) | 1.92521544 |
| 110 | Cortical visual impairment (HP:0100704) | 1.91906690 |
| 111 | Macroorchidism (HP:0000053) | 1.91821305 |
| 112 | Exotropia (HP:0000577) | 1.89771784 |
| 113 | Abnormality of glycolipid metabolism (HP:0010969) | 1.87199753 |
| 114 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.87199753 |
| 115 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.87199753 |
| 116 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.86839086 |
| 117 | Villous atrophy (HP:0011473) | 1.86839086 |
| 118 | Protuberant abdomen (HP:0001538) | 1.84705440 |
| 119 | Hyperphosphaturia (HP:0003109) | 1.83146173 |
| 120 | Intestinal atresia (HP:0011100) | 1.79716784 |
| 121 | Type I diabetes mellitus (HP:0100651) | 1.79231411 |
| 122 | Intention tremor (HP:0002080) | 1.78655095 |
| 123 | Tachypnea (HP:0002789) | 1.75816243 |
| 124 | Hypokalemic alkalosis (HP:0001949) | 1.75736140 |
| 125 | Athetosis (HP:0002305) | 1.75590176 |
| 126 | Intrahepatic cholestasis (HP:0001406) | 1.74259603 |
| 127 | Deep venous thrombosis (HP:0002625) | 1.74180352 |
| 128 | Sprengel anomaly (HP:0000912) | 1.73754847 |
| 129 | Skin nodule (HP:0200036) | 1.73716889 |
| 130 | Downturned corners of mouth (HP:0002714) | 1.72525856 |
| 131 | Generalized hyperpigmentation (HP:0007440) | 1.70985098 |
| 132 | Orthostatic hypotension (HP:0001278) | 1.70417601 |
| 133 | Missing ribs (HP:0000921) | 1.70336903 |
| 134 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.70304910 |
| 135 | Vascular calcification (HP:0004934) | 1.70221029 |
| 136 | Neoplasm of the heart (HP:0100544) | 1.69498199 |
| 137 | Failure to thrive in infancy (HP:0001531) | 1.66094920 |
| 138 | Abnormality of renal excretion (HP:0011036) | 1.65030787 |
| 139 | Type II lissencephaly (HP:0007260) | 1.63554248 |
| 140 | Hyperaldosteronism (HP:0000859) | 1.63464937 |
| 141 | Severe short stature (HP:0003510) | 1.62375402 |
| 142 | Akinesia (HP:0002304) | 1.60675554 |
| 143 | Type II diabetes mellitus (HP:0005978) | 1.60647128 |
| 144 | Deformed sella turcica (HP:0002681) | 1.60558142 |
| 145 | Testicular neoplasm (HP:0010788) | 1.60239840 |
| 146 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.60061545 |
| 147 | Enlarged epiphyses (HP:0010580) | 1.59562661 |
| 148 | Muscular hypotonia of the trunk (HP:0008936) | 1.59551395 |
| 149 | Myokymia (HP:0002411) | 1.59454057 |
| 150 | Resting tremor (HP:0002322) | 1.59241385 |
| 151 | Irregular vertebral endplates (HP:0003301) | 1.57915151 |
| 152 | Abnormality of the common coagulation pathway (HP:0010990) | 1.56154226 |
| 153 | Disproportionate short-trunk short stature (HP:0003521) | 1.55763098 |
| 154 | Widely patent fontanelles and sutures (HP:0004492) | 1.54479157 |
| 155 | Truncus arteriosus (HP:0001660) | 1.54278024 |
| 156 | Depression (HP:0000716) | 1.53701984 |
| 157 | Ankle clonus (HP:0011448) | 1.48705691 |
| 158 | Postural tremor (HP:0002174) | 1.48248142 |
| 159 | Increased IgE level (HP:0003212) | 1.48201935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 7.26026830 |
| 2 | PASK | 5.83211066 |
| 3 | MAPK15 | 5.59962358 |
| 4 | TAOK3 | 3.78585392 |
| 5 | PRKD3 | 3.28889731 |
| 6 | PDK2 | 3.23596222 |
| 7 | HIPK2 | 3.16905060 |
| 8 | WNK3 | 2.88078000 |
| 9 | MAP3K2 | 2.78754031 |
| 10 | FRK | 2.65505343 |
| 11 | WNK4 | 2.43664544 |
| 12 | CASK | 2.40492241 |
| 13 | DAPK2 | 2.40249148 |
| 14 | ERN1 | 2.30886186 |
| 15 | FLT3 | 2.11531200 |
| 16 | UHMK1 | 2.03978047 |
| 17 | SMG1 | 1.93576186 |
| 18 | NTRK1 | 1.92672469 |
| 19 | MAP3K9 | 1.91636030 |
| 20 | SCYL2 | 1.85065394 |
| 21 | MAP3K1 | 1.74390699 |
| 22 | CAMKK2 | 1.60598822 |
| 23 | PIK3CG | 1.60439973 |
| 24 | NTRK3 | 1.58842337 |
| 25 | STK38 | 1.54252795 |
| 26 | PKN2 | 1.47318291 |
| 27 | EPHA4 | 1.43781438 |
| 28 | PDGFRA | 1.43252391 |
| 29 | PAK6 | 1.41615148 |
| 30 | MST4 | 1.38866812 |
| 31 | IRAK3 | 1.36368726 |
| 32 | EPHA3 | 1.34117083 |
| 33 | MAP2K6 | 1.27025742 |
| 34 | MAP3K12 | 1.26377410 |
| 35 | CDC42BPA | 1.26018302 |
| 36 | PTK2 | 1.21791776 |
| 37 | PRKCH | 1.18045602 |
| 38 | BRSK2 | 1.16835921 |
| 39 | IRAK1 | 1.16430822 |
| 40 | DYRK1B | 1.14561697 |
| 41 | TRIB3 | 1.14275339 |
| 42 | PAK3 | 1.10229416 |
| 43 | PDPK1 | 1.08182937 |
| 44 | PTK6 | 0.99787929 |
| 45 | PRKD2 | 0.98660596 |
| 46 | FGFR2 | 0.94364555 |
| 47 | AKT3 | 0.92357116 |
| 48 | MINK1 | 0.92012415 |
| 49 | MET | 0.90362264 |
| 50 | PDK1 | 0.89851215 |
| 51 | MARK1 | 0.87702153 |
| 52 | WNK1 | 0.85859679 |
| 53 | EIF2AK3 | 0.84274482 |
| 54 | MAP2K2 | 0.83223470 |
| 55 | PINK1 | 0.81721021 |
| 56 | DAPK1 | 0.79613259 |
| 57 | PHKG1 | 0.73674561 |
| 58 | PHKG2 | 0.73674561 |
| 59 | ICK | 0.70139900 |
| 60 | SIK1 | 0.67977895 |
| 61 | RET | 0.63126201 |
| 62 | FER | 0.61860440 |
| 63 | BRSK1 | 0.61759800 |
| 64 | BRD4 | 0.60781255 |
| 65 | IRAK2 | 0.60482166 |
| 66 | ARAF | 0.58596094 |
| 67 | BRAF | 0.58370296 |
| 68 | SGK3 | 0.57789990 |
| 69 | PRKCE | 0.56388617 |
| 70 | CAMK2D | 0.56053497 |
| 71 | PRKCI | 0.54512233 |
| 72 | ITK | 0.53423479 |
| 73 | TESK1 | 0.53295083 |
| 74 | JAK2 | 0.52751475 |
| 75 | BCKDK | 0.50605162 |
| 76 | KSR2 | 0.50224721 |
| 77 | CAMKK1 | 0.49253990 |
| 78 | PRKAA1 | 0.49088121 |
| 79 | MAPK12 | 0.49051031 |
| 80 | PRPF4B | 0.48948074 |
| 81 | NTRK2 | 0.48548506 |
| 82 | MAP3K4 | 0.48256428 |
| 83 | AKT2 | 0.47814944 |
| 84 | ERBB2 | 0.47528831 |
| 85 | EPHB1 | 0.47067058 |
| 86 | LATS2 | 0.46239178 |
| 87 | STK11 | 0.44715569 |
| 88 | TAOK1 | 0.42498989 |
| 89 | DAPK3 | 0.42378289 |
| 90 | MAPK7 | 0.41744837 |
| 91 | MAP2K4 | 0.41351182 |
| 92 | MARK2 | 0.40571802 |
| 93 | RPS6KA2 | 0.40032026 |
| 94 | NLK | 0.38539877 |
| 95 | KSR1 | 0.38263904 |
| 96 | GSK3A | 0.37434379 |
| 97 | FGFR4 | 0.36791627 |
| 98 | STK24 | 0.36297552 |
| 99 | PRKD1 | 0.36095413 |
| 100 | EPHA2 | 0.35891700 |
| 101 | CDK5 | 0.35369822 |
| 102 | PRKACG | 0.34634829 |
| 103 | CAMK1G | 0.34618141 |
| 104 | CSNK1E | 0.34376646 |
| 105 | CSNK1A1 | 0.34002632 |
| 106 | MAP3K3 | 0.33693510 |
| 107 | CAMK2B | 0.33261413 |
| 108 | MTOR | 0.32919411 |
| 109 | LRRK2 | 0.31550934 |
| 110 | JAK1 | 0.31330229 |
| 111 | CDK14 | 0.30966471 |
| 112 | BCR | 0.30435678 |
| 113 | ROCK1 | 0.30414364 |
| 114 | SGK1 | 0.30217256 |
| 115 | PRKCZ | 0.29628577 |
| 116 | PRKDC | 0.29620564 |
| 117 | PRKG2 | 0.29053928 |
| 118 | ZAP70 | 0.28661432 |
| 119 | PRKACA | 0.27663767 |
| 120 | IGF1R | 0.27432165 |
| 121 | CAMK1D | 0.27357106 |
| 122 | STK38L | 0.27231863 |
| 123 | RIPK1 | 0.27220399 |
| 124 | MAPK4 | 0.26818381 |
| 125 | ALK | 0.25882131 |
| 126 | PDGFRB | 0.25453502 |
| 127 | RPS6KB1 | 0.24649706 |
| 128 | JAK3 | 0.23054614 |
| 129 | MAPK14 | 0.23033100 |
| 130 | DYRK1A | 0.23002952 |
| 131 | SGK494 | 0.22570481 |
| 132 | SGK223 | 0.22570481 |
| 133 | MAP2K1 | 0.22016120 |
| 134 | GRK5 | 0.21554617 |
| 135 | PRKCG | 0.20326605 |
| 136 | DYRK3 | 0.20000469 |
| 137 | NEK6 | 0.19670133 |
| 138 | PRKCA | 0.18473745 |
| 139 | ADRBK1 | 0.18387044 |
| 140 | RPS6KA3 | 0.18300216 |
| 141 | FGFR3 | 0.16967170 |
| 142 | CHUK | 0.16370499 |
| 143 | MAPK10 | 0.16223533 |
| 144 | CSK | 0.14813693 |
| 145 | BMPR2 | 0.13825005 |
| 146 | AKT1 | 0.12796928 |
| 147 | IRAK4 | 0.11890573 |
| 148 | MAPK9 | 0.11664524 |
| 149 | PRKCB | 0.11443042 |
| 150 | SGK2 | 0.11217929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.35213475 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.18272111 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.79879124 |
| 4 | Insulin secretion_Homo sapiens_hsa04911 | 3.44593956 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.24956504 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.03197133 |
| 7 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.54636294 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.43925922 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.14551289 |
| 10 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.93488352 |
| 11 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74194651 |
| 12 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.72071676 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.64304151 |
| 14 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.61640180 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.50761890 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49243307 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.41024139 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.35475877 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.32789741 |
| 20 | Mineral absorption_Homo sapiens_hsa04978 | 1.32597329 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.31730512 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.24452438 |
| 23 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.21798993 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.21314695 |
| 25 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18733684 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17982215 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.17705391 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.16748277 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.13668538 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.13530303 |
| 31 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.11192116 |
| 32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.09621574 |
| 33 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09120740 |
| 34 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.06780349 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.05546682 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.03520464 |
| 37 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02696202 |
| 38 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97693563 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.97218100 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.96541706 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95936215 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.95892451 |
| 43 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.95289960 |
| 44 | Insulin resistance_Homo sapiens_hsa04931 | 0.93831225 |
| 45 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92712597 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.87702608 |
| 47 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87392080 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 0.87357070 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 0.87202737 |
| 50 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85517073 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.83262728 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82352210 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.81215201 |
| 54 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.80890617 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80691278 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79710021 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.76691315 |
| 58 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74969900 |
| 59 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74351605 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73911173 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.66049863 |
| 62 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65863282 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64909598 |
| 64 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64651114 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62711968 |
| 66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60666281 |
| 67 | Tight junction_Homo sapiens_hsa04530 | 0.60158299 |
| 68 | Alcoholism_Homo sapiens_hsa05034 | 0.56888646 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56688844 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56246472 |
| 71 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.53883207 |
| 72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52592753 |
| 73 | Renin secretion_Homo sapiens_hsa04924 | 0.51719999 |
| 74 | Morphine addiction_Homo sapiens_hsa05032 | 0.51197048 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48792697 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48492941 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.48447175 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.46573606 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46365328 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46103200 |
| 81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.44951037 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42889595 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.42659588 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42612446 |
| 85 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.41983933 |
| 86 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41872396 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40086434 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.39683780 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39578378 |
| 90 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38437743 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37824575 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.36235400 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35127640 |
| 94 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.35019208 |
| 95 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33574868 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.33295572 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33177049 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33035934 |
| 99 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32877282 |
| 100 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32525331 |
| 101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.31957991 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.31544616 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31079810 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30063124 |
| 105 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29344177 |
| 106 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.29178695 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29094958 |
| 108 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.28755454 |
| 109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.27362142 |
| 110 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27147742 |
| 111 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27098147 |
| 112 | Lysine degradation_Homo sapiens_hsa00310 | 0.26731583 |
| 113 | Axon guidance_Homo sapiens_hsa04360 | 0.24619401 |
| 114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24051468 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.23853162 |
| 116 | Focal adhesion_Homo sapiens_hsa04510 | 0.23588736 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22332948 |
| 118 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22251299 |
| 119 | Histidine metabolism_Homo sapiens_hsa00340 | 0.22231060 |
| 120 | Melanogenesis_Homo sapiens_hsa04916 | 0.21940458 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.21722410 |
| 122 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.21324282 |
| 123 | Olfactory transduction_Homo sapiens_hsa04740 | 0.21224258 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.20805829 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.20460186 |
| 126 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.19991338 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19314099 |
| 128 | Glioma_Homo sapiens_hsa05214 | 0.18990585 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.16681272 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14578409 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.14051557 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13181756 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.11402073 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.09775945 |

